£23.7M
The Series B round was led by the Blue Venture Fund to accelerate the deployment of artificial intelligence in echocardiography.
Ultromics
Ultromics develops artificial intelligence software for automated cardiovascular imaging and diagnostics.
£23.7MTotal raised
Ultromics develops artificial intelligence powered software that automates echocardiogram analysis to aid in the diagnosis of cardiovascular disease. The company spun out from the University of Oxford and works alongside the National Health Service.
Categories
Founders
Ross Upton
CEO and co-founder
Ross leads Ultromics as founder, chief executive, and chief scientific officer while maintaining a research role at the University of Oxford. He also contributes to committees at the National Institutes of Health.
LinkedIn